Noticias Institucionales

14 Nov 2007

Biologist Marco Milán, Drosophila researcher at IRB Barcelona, has been awarded the EMBO Young Investigator Programme, given by the European Molecular Biology Organization (EMBO) to promising young European scientists for their early career excellence. The programme has been identifying and supporting on an annual basis some of the brightest young researchers in Europe since 2000.

<p>FEBS Secretary General Elect, Isarel Pecht, presents Joan Guinovart with the <i>Diplome D'Honneur</i></p>
9 Jul 2007

IRB Barcelona director, Joan J. Guinovart, was awarded today the Federation of European Biochemical Societies' (FEBS) Diplome d'Honneur, in recognition of Guinovart's contributions to the advancement of science in Europe. "I am deeply grateful to FEBS for this honour, which holds particular meaning for me." Guinovart received the award during the inaugural ceremony of FEBS' annual congress, held this year in Vienna, Austria.

Joan J. Guinovart has been director of IRB Barcelona since its foundation, and is president of the Confederation of Spanish Scientific Societies (COSCE), an initiative launched in 2004 to promote scientific and technological development in Spain...

18 Jun 2007

Fifteen international researchers will discuss new scientific evidence associating chronic inflammation with a long list of diseases.

22 May 2007

As part of the "Year of Science 2007", the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Centre – Centro Nacional de Supercomputación (BSC-CNS) will gather around 150 scientists from prominent biomedical research institutes and centres in Spain, to present the supercomputing opportunities offered by the MareNostrum in the field of the life sciences. The scientific conference, “Computational Biology: Biomolecular Simulations, Bioinformatics and Supercomputing”, will be held from 24-25 May at the Campus Nord at the Universitat Politècnica de Catalunya (UPC).

"MareNostrum optimus est", states Joan J. Guinovart, director of IRB Barcelona -...

<p>Participants in the round table 'The impact of cancer research'.</p>
26 Apr 2007

Big business, represented by Francisco González, president of the Fundación BBVA, and science, represented by Joan Massagué, adjunct director of the Institute for Research in Biomedicine (IRB Barcelona) met today at the Barcelona BioMed Forum, “Science, Economy and Society: invest in cancer research,” to discuss the future of cancer research and the role that big business can play in advancing biomedicine. The event, which took place in the Antoni Caparrós auditorium of the Barcelona Science Park (Parc Científic de Barcelona) was inaugurated by the Government of Catalonia’s Minister of Health, Marina Geli.

In conveying the Government’s enthusiasm to participate in the Forum,...

<p><p>Francisco González, president of the Fundación BBVA, and Joan Massagué, adjunct director of IRB Barcelona during a visit to the Metastasis Laboratory promoted by Massagué.</p></p>
19 Apr 2007

Gaining precise and sophisticated knowledge about the basic mechanisms of cancer and its transition to metastasis remains one of the great challenges for biomedical research. The enormous social and economic impact of the disease obliges us to explore “new forms of commitment” to accelerate cancer research, and its resulting applications in terms of therapy and prevention. This was the inaugural message of the first Barcelona Biomed Forum, celebrated today by the Institute for Research in Biomedicine (IRB Barcelona) and the Fundación BBVA (of the Banco Bilbao Vizcaya Argentaria). The event, “Science, Economy and Society: invest in cancer research” brought together scientific expert Joan...

<p>Centromeres (pictured) play a critical role in chromosome segregation and cell proliferation. their function is determined epigenetically by a variation of the histone H3. Image by Olga Moreno, IRB Barcelona</p>
19 Mar 2007

International experts on epigenetics will meet at the upcoming Barcelona BioMed Conference organised by IRB Barcelona and the BBVA Foundation.

<p>MELIUS project logo</p>
15 Feb 2007

The research project “Improvement of the translational prediction of non-clinical assays in humans" (MELIUS), coordinated by Neuropharma S.A., part of the Zeltia group, and which involves the IRB Barcelona research group “Metabolic engineering and diabetes”, headed by Joan J. Guinovart, is one of 15 projects awarded funding through the CENIT programme by the Ministry of Industry, Commerce and Tourism.

MELIUS is the only project in biomedicine that will receive R+D+i funding through the CENIT programme. This project seeks to develop new tools to improve the prediction of...

<p>Double-stranded RNA molecules trigger the sequence specific gene silencing response known as RNA interference.<br> Graphic provided by M. Orozco group (IRB Barcelona)</p>
11 Dec 2006

The topic of this conference won the Nobel Prize in Medicine and Physiology this year.

19 Oct 2006

The first of the Barcelona BioMed Conferences will focus on Nuclear Magnetic Resonance and its role in drug discovery.